General Capital Limited (NZE:GEN)

Market Cap	23.88M
Revenue (ttm)	10.56M
Net Income (ttm)	2.81M
Shares Out	91.83M
EPS (ttm)	0.03
PE Ratio	8.43
Forward PE	n/a
Dividend	0.01 (3.07%)
Ex-Dividend Date	Jun 12, 2025

Volume	21
Average Volume	17,200
Open	0.2600
Previous Close	0.2600
Day's Range	0.2600 - 0.2600
52-Week Range	0.1850 - 0.3400
Beta	0.70
RSI	33.22
Earnings Date	Aug 22, 2025

About Orchard Therapeutics

General Capital Limited, together with its subsidiaries, provides financial services in New Zealand. The company operates three segments: Finance, Research and Advisory, and corporate and other segments. It accepts deposits; and offers short term property mortgage lending, and insurance premium funding services. The company also provides investment advisory services; and produces and sells investment research and publications. In addition, it is involved in research and advisory; and investment activities. General Capital Limited is based in Au...

• Industry: Financial - Mortgages
• Sector: Financials
• CEO: Brent King
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: GEN

Financial Performance

In 2024, General Capital's revenue was 10.56 million, an increase of 17.07% compared to the previous year's 9.02 million. Earnings were 2.81 million, an increase of 6.56%.